Yüklüyor......

IGHV Mutational Status Testing in Chronic Lymphocytic Leukemia

As the therapeutic landscape for chronic lymphocytic leukemia (CLL) continues to expand, biological predictors of response to therapy are becoming increasingly important. One such predictive biomarker is the mutational status of the variable region of the immunoglobulin heavy chain (IGHV) gene, whic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Hematol
Asıl Yazarlar: Crombie, Jennifer, Davids, Matthew S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5675754/
https://ncbi.nlm.nih.gov/pubmed/28589701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24808
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!